Total submissions: 8
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Eurofins Ntd Llc |
RCV000723615 | SCV000113450 | uncertain significance | not provided | 2013-05-09 | criteria provided, single submitter | clinical testing | |
Laboratory for Molecular Medicine, |
RCV000156059 | SCV000205772 | benign | not specified | 2018-05-10 | criteria provided, single submitter | clinical testing | The c.81+5delG variant in DNAI1 is classified as benign because it has been iden tified in 3% (1022/34400) of Latino chromosomes, including 23 homozygotes, by th e Genome Aggregation Database (gnomAD, http://gnomad.broadinstitute.org; dbSNP r s200411544). This deletion occurs within the splice site consensus sequence and is predicted to impact splicing by computational prediction tools. ACMG/AMP Crit eria applied: BA1; PP3. |
Labcorp Genetics |
RCV001081396 | SCV000255001 | benign | Primary ciliary dyskinesia | 2024-01-29 | criteria provided, single submitter | clinical testing | |
Gene |
RCV000723615 | SCV001833278 | benign | not provided | 2020-09-15 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV001081396 | SCV002679020 | benign | Primary ciliary dyskinesia | 2015-06-03 | criteria provided, single submitter | clinical testing | This alteration is classified as benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
ARUP Laboratories, |
RCV003114245 | SCV003800280 | benign | Kartagener syndrome | 2023-09-13 | criteria provided, single submitter | clinical testing | |
Prevention |
RCV004754297 | SCV000311867 | benign | DNAI1-related disorder | 2024-05-17 | no assertion criteria provided | clinical testing | This variant is classified as benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). |
Natera, |
RCV001081396 | SCV001458179 | benign | Primary ciliary dyskinesia | 2020-09-16 | no assertion criteria provided | clinical testing |